BLUEPRINT MEDICINES CORP's ticker is and the CUSIP is 09627Y909. A total of 3 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,959,000 | -27.0% | 50,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,054,000 | +341.6% | 50,600 | +411.1% | 0.00% | – |
| Q2 2019 | $918,000 | -60.8% | 9,900 | -67.0% | 0.00% | – |
| Q3 2018 | $2,342,000 | +23.0% | 30,000 | 0.0% | 0.00% | – |
| Q2 2018 | $1,904,000 | -23.1% | 30,000 | +11.1% | 0.00% | -100.0% |
| Q1 2018 | $2,476,000 | – | 27,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 45,100 | $2,278,000 | 0.00% |
| SIMPLEX TRADING, LLC | 22,100 | $1,116,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 6,200 | $313,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |